|
 |
| A variety of
major advances over the past five years have transformed the
drug development process. Conferences in CHI’s Drug
Discovery & Development Series focus on these
technological breakthroughs and include aspects of
combinatorial chemistry, high-throughput screening, and
genomics as it relates to drug discovery. Researchers and
executives in major Pharmaceutical organizations, biotech
companies, as well as government and academic institutes find
these conferences offer a means to interact with industry
leaders and learn what developments will impact the future of
this industry. From very specific discovery aspects to the
latest cutting-edge development techniques the DD&D
conference series offers the most in-depth coverage of a
rapidly evolving field.
|
|
|
|
PEGS
2007
Phage
Display Therapeutics
Difficult
to Express Proteins
Engineering
Proteins for Delivery
Recombinant
Antibodies
Monoclonal
Antibodies
Executive Summit
|
|
|
|
|
CELLutions
Summit
- Guide
to GLP
- Biomarker Discovery Summit
- Quantitative PCR
- Next Generation
Recombinant Antibodies Europe Conference
|
|
|
|
|
